News

FDA tells White House to scale back plans to offer boost shots

FDA wants more time to review data

The New York Times reports that officials have told the White House to scale back plans to offer covid booster shots to the general public by Sept 20.

The FDA warned it might only recommend boosters for Pfizer vaccine recipients and possibly only some of them to start. On Moderna, the report says this:

Among the reasons for delaying is that regulators need more time to
decide the proper dosage for a possible third Moderna shot. The
company’s application asking the F.D.A. to authorize a booster shot
contains insufficient data, one federal official familiar with the
process said.

The FDA hasn’t received the raw data from Israel, which is already delivering third doses to everyone.

Invest in yourself. See our forex education hub.

Articles You May Like

ForexLive Asia-Pacific FX news wrap: USD inches higher
U. of Michigan consumer sentiment prelim survey for August rises to 55.1 vs. 52.5 estimate
Epic USD collapse following downside CPI surprise unlikely to stick – TDS
Gold eases as investors focus on U.S. inflation data
KBW 2022: Crypto.com hits key regulatory milestone in South Korea

Leave a Reply

Your email address will not be published.